July 8 (Reuters) - Hong Kong-listed drugmaker Sino Biopharmaceutical said on Wednesday its China unit had secured rights to ...

Opinions expressed by Digital Journal contributors are their own. As healthcare systems worldwide continue to address the effects of the COVID-19 pandemic, pharmaceutical companies like Amneal ...

AstraZeneca has been reprimanded by the U.K. drug marketing authority for a series of breaches of its code of conduct across its website for its respiratory franchise. A healthcare professional in the ...

April 7 (Reuters) - Pfizer Inc (PFE.N), opens new tab said on Thursday it would buy privately-held ReViral Ltd in a deal worth as much as $525 million including milestone payments, to gain access to ...

HANGZHOU, China, May 7, 2026 /PRNewswire/ -- Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative ...

Feb 13 (Reuters) - India's GlaxoSmithKline Pharmaceuticals (GLAX.NS), opens new tab reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and ...

In early April, Pfizer announced a $525 million acquisition of ReViral’s novel therapy for respiratory syncytial virus (RSV). Since then, RSV therapies have garnered renewed global attention. However, ...

In a fourth-quarter conference call, Insmed CEO Will Lewis admitted that it was “audacious” that his company would project sales of newly approved respiratory drug Brinsupri to reach $1 billion in ...

LONDON--(BUSINESS WIRE)--SpectrumX, a UK-based healthcare and pharmaceutical company, today announces that following a constructive scientific advice meeting with the Medicines and Healthcare products ...

An oral antiviral drug that targets a key part of the respiratory syncytial virus (RSV) polymerase and inhibits the synthesis of viral genetic material has been identified, a finding that could ...

Sino Biopharmaceutical will receive $200 million upfront from AstraZeneca, and will be eligible for milestone payments.

Hospitals across the U.S. face shortages of the drug albuterol, used to treat respiratory illnesses. Supplies of the drug were reduced over a fall and winter by patients with RSV, influenza and ...